The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer’s disease

Richard A. Armstrong

Research output: Contribution to journalArticle

Abstract

Since the earliest descriptions of the disease, senile plaques (SP) and neurofibrillary tangles (NFT) have been regarded as the pathological 'hallmarks' of Alzheimer's disease (AD). Whether or not SP and NFT are sufficient cause to explain the neurodegeneration of AD is controversial. The major molecular constituents of these lesions, viz., beta-amyloid (Ass) and tau, have played a defining role both in the diagnosis of the disease and in studies of pathogenesis. The molecular biology of SP and NFT, however, is complex with many chemical constituents. An individual constituent could be the residue of a pathogenic gene mutation, result from cellular degeneration, or reflect the acquisition of new proteins by diffusion and molecular binding. This review proposes that the molecular composition of SP and NFT is largely a consequence of cell degeneration and the later acquisition of proteins. Such a conclusion has implications both for the diagnosis of AD and in studies of disease pathogenesis.
LanguageEnglish
Pages289-99
Number of pages11
JournalFolia Neuropathologica
Volume47
Issue number4
Publication statusPublished - 29 Dec 2009

Fingerprint

Neurofibrillary Tangles
Amyloid Plaques
Molecular Biology
Alzheimer Disease
Equidae
Amyloid
Proteins
Mutation
Genes

Bibliographical note

Creative Commons Attribution Non-Commercial Share Alike International 4.0

Keywords

  • Alzheimer’s disease
  • senile plaque
  • neurofibrillary tangle
  • ß-amyloid
  • molecular composition
  • gene mutation
  • disease pathogenesis

Cite this

@article{625171473b4344d1a75a748c7c5743e6,
title = "The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer’s disease",
abstract = "Since the earliest descriptions of the disease, senile plaques (SP) and neurofibrillary tangles (NFT) have been regarded as the pathological 'hallmarks' of Alzheimer's disease (AD). Whether or not SP and NFT are sufficient cause to explain the neurodegeneration of AD is controversial. The major molecular constituents of these lesions, viz., beta-amyloid (Ass) and tau, have played a defining role both in the diagnosis of the disease and in studies of pathogenesis. The molecular biology of SP and NFT, however, is complex with many chemical constituents. An individual constituent could be the residue of a pathogenic gene mutation, result from cellular degeneration, or reflect the acquisition of new proteins by diffusion and molecular binding. This review proposes that the molecular composition of SP and NFT is largely a consequence of cell degeneration and the later acquisition of proteins. Such a conclusion has implications both for the diagnosis of AD and in studies of disease pathogenesis.",
keywords = "Alzheimer’s disease, senile plaque, neurofibrillary tangle, {\ss}-amyloid, molecular composition, gene mutation, disease pathogenesis",
author = "Armstrong, {Richard A.}",
note = "Creative Commons Attribution Non-Commercial Share Alike International 4.0",
year = "2009",
month = "12",
day = "29",
language = "English",
volume = "47",
pages = "289--99",
journal = "Folia Neuropathologica",
issn = "1641-4640",
publisher = "Polish Association of Neuropathologists",
number = "4",

}

The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer’s disease. / Armstrong, Richard A.

In: Folia Neuropathologica, Vol. 47, No. 4, 29.12.2009, p. 289-99.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer’s disease

AU - Armstrong, Richard A.

N1 - Creative Commons Attribution Non-Commercial Share Alike International 4.0

PY - 2009/12/29

Y1 - 2009/12/29

N2 - Since the earliest descriptions of the disease, senile plaques (SP) and neurofibrillary tangles (NFT) have been regarded as the pathological 'hallmarks' of Alzheimer's disease (AD). Whether or not SP and NFT are sufficient cause to explain the neurodegeneration of AD is controversial. The major molecular constituents of these lesions, viz., beta-amyloid (Ass) and tau, have played a defining role both in the diagnosis of the disease and in studies of pathogenesis. The molecular biology of SP and NFT, however, is complex with many chemical constituents. An individual constituent could be the residue of a pathogenic gene mutation, result from cellular degeneration, or reflect the acquisition of new proteins by diffusion and molecular binding. This review proposes that the molecular composition of SP and NFT is largely a consequence of cell degeneration and the later acquisition of proteins. Such a conclusion has implications both for the diagnosis of AD and in studies of disease pathogenesis.

AB - Since the earliest descriptions of the disease, senile plaques (SP) and neurofibrillary tangles (NFT) have been regarded as the pathological 'hallmarks' of Alzheimer's disease (AD). Whether or not SP and NFT are sufficient cause to explain the neurodegeneration of AD is controversial. The major molecular constituents of these lesions, viz., beta-amyloid (Ass) and tau, have played a defining role both in the diagnosis of the disease and in studies of pathogenesis. The molecular biology of SP and NFT, however, is complex with many chemical constituents. An individual constituent could be the residue of a pathogenic gene mutation, result from cellular degeneration, or reflect the acquisition of new proteins by diffusion and molecular binding. This review proposes that the molecular composition of SP and NFT is largely a consequence of cell degeneration and the later acquisition of proteins. Such a conclusion has implications both for the diagnosis of AD and in studies of disease pathogenesis.

KW - Alzheimer’s disease

KW - senile plaque

KW - neurofibrillary tangle

KW - ß-amyloid

KW - molecular composition

KW - gene mutation

KW - disease pathogenesis

UR - http://www.scopus.com/inward/record.url?scp=75149142375&partnerID=8YFLogxK

UR - http://www.termedia.pl/Journal/Folia_Neuropathologica-20/Streszczenie-13830

M3 - Article

VL - 47

SP - 289

EP - 299

JO - Folia Neuropathologica

T2 - Folia Neuropathologica

JF - Folia Neuropathologica

SN - 1641-4640

IS - 4

ER -